ISTH 2020 Congress
Hemophilia and Rare Bleeding Disorders » Management of Bleeding and Trauma
Theme Navigation
- ISTH 2020 Congress
- Hemophilia and Rare Bleeding Disorders
- Management of Bleeding and Trauma
- Hemophilia and Rare Bleeding Disorders
Abstract Number: PB1111
Activated Prothrombin Complex Concentrates for the Management of Direct Oral Anticoagulant-Associated Bleeding Events and Pre-Operative Administration for Urgent Surgery: Hemostatic and Thrombotic Outcomes
Abstract Number: PB1119
Andexanet and Prothrombin Complex Concentrate Give Comparable Haemostatic Efficacy for Major Bleeding in Patients on Factor Xa Inhibitors
Abstract Number: PB1136
Biomarkers of Fibrinolysis Predict the Need for Massive Transfusion in Trauma
Abstract Number: PB1117
Continuous Infusion with Kovaltry (Octocog Alfa) during Cardiac Surgery for Tetralogy of Fallot in an Hemophilic Child
Abstract Number: PB1133
Desmopressin Response and Clinical Outcome in Bleeding Disorders: A 30 Year Retrospective Analysis
Abstract Number: PB1128
Direct Oral Anticoagulants Bleeding Events in Patients with Atrial Fibrillation Vs Venous Thromboembolism Admitted to an Emergency Department: Real-Life Study
Abstract Number: PB1113
Effect of Oral Anticoagulant Use on Surgical Delay and Outcomes in Hip Fracture Patients: A Systematic Review and Meta-Analysis
Abstract Number: PB1116
Effect of rFVIIa on Thromboelastogram Parameters in Haemophilia A Patients with Inhibitor
Abstract Number: PB1127
Endovascular Abdominal Aortic Aneurysm Repair in a Mild Haemophilia A Patient: A Case Report
Abstract Number: PB1132
Extended Half-life FIX and Disruptive Therapies in Carriers with FVIII and FIX Deficiencies: Preliminary Experience
Abstract Number: PB1134
Glycocalyx Shedding as a Potential Driver of Trauma-induced Coagulopathy in Severe Trauma Patients: Insights from the TRAUCC Trial
Abstract Number: PB1121
Idarucizumab to Neutralize Dabigatran in a University Hospital: The Relevance of Renal Function
Abstract Number: PB1130
Improved Sensitivity of Global Hemostasis Assays Using Different Combinations of Phospholipid Reagent and Tissue Factor
Abstract Number: PB1139
Intravenous Synthetic Platelet Nanotechnology for the Treatment of Bleeding Complications
Abstract Number: PB1115
Low-Factor Consumption and Cost Effectiveness for Surgeries in Hemophilia B Patients with N9-GP
Abstract Number: PB1122
Methodological and Reporting Quality in Case Series of Four-Factor Prothrombin Complex Concentrate in the Management of Oral Factor Xa Inhibitor-Associated Bleeding
Abstract Number: PB1112
Reversal of Direct Oral Anticoagulants with Three-Factor Prothrombin Complex Concentrate: Real World Experience from a Tertiary Centre in Hong Kong
Abstract Number: PB1140
The 2020 World Federation of Hemophilia Guidelines for the Management of Hemophilia
Abstract Number: PB1129
The Age Dependent Effects of Female Sex on Platelet Behavior after Injury